T
SZYM

Tahithromos’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Tahithromos’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-277,079
Closed -$870K – 20
2015
Q2 		$870K Sell
277,079
-452,646
-62% -$1.55M 1.2% 13
2015
Q1 		$2.09M Sell
729,725
-1,221,813
-63% -$3.12M 0.97% 27
2014
Q4 		$5.04M Sell
1,951,538
-421,418
-18% -$1.84M 2.42% 17
2014
Q3 		$17.7M Buy
2,372,956
+1,845,481
+350% +$17.2M 4.6% 8
2014
Q2 		$6.21M Buy
+527,475
New +$5.62M 1.48% 23

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tahithromos's SZYM Position: Q3 2015 in Review

Tahithromos sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q3 2015, closing a stake of 277,079 shares — an estimated $870K sold.

Tahithromos first reported a position in SZYM in Q2 2014 and held it in 5 quarters. The position peaked at $17.7M in Q3 2014. 101 funds tracked by Wall St. Rank hold SZYM as of Q3 2015.

  • Tahithromos reported no remaining SOLAZYME INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Tahithromos sold 277,079 SOLAZYME INC COM STK (DE) shares in Q3 2015, an estimated $870K.
  • Tahithromos first reported a position in SOLAZYME INC COM STK (DE) in Q2 2014 and held it in 5 quarters.
  • Tahithromos's SOLAZYME INC COM STK (DE) position peaked at $17.7M in Q3 2014.
  • 101 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q3 2015.

Based on Tahithromos's 13F filing for Q3 2015, filed 28 Oct 2015.